Stay updated with breaking news from Processa Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Processa Pharmaceuticals, Inc. (PCSA) announced that after the meeting with the FDA, it has decided to expand the development of Next Generation Capecitabine or NGC-Cap into the treatment of advanced or metastatic breast cancer beginning with its next Phase 2 trial.
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Friday. The Dow traded up 0.41% to 37,621.27 while the NASDAQ rose 0.66% to 15,154.43. The S&P 500 also rose, gaining, 0.46% to 4,803.12.
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the consensus of $1.532 billion. Adjusted EPS of 25 cents topped the street view of 23 cents.
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 1% on Thursday. The Dow traded down 0.02% to 37,257.79 while the NASDAQ rose 1.19% to 15,032.26. The S&P 500 also rose, gaining, 0.49% to 4,762.36.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.35% to 37,398.50 while the NASDAQ rose 1.16% to 15,027.63. The S&P 500 also rose, gaining, 0.67% to 4,770.73.